Pharmabiz4h
Therapy helps peanut-allergic kids tolerate tablespoons of peanut butter: NIH study
Therapy helps peanut-allergic kids tolerate tablespoons of peanut butter: NIH study: Bethesda, Maryland Wednesday, February 12, 2025, 18:00 Hrs [IST] Eating gradually increasing d ...
Pharmabiz7h
Nivaan Care pain management clinic chain raises $4.25 million in seed fund from Endiya Partners and W Health Ventures
Nivaan Care pain management clinic chain raises $4.25 million in seed fund from Endiya Partners and W Health Ventures: Our Bureau, Bengaluru Wednesday, February 12, 2025, 15:30 Hr ...
Pharmabiz6h
INmune Bio to submit BLA with US FDA seeking approval of CORDStrom to treat recessive dystrophic epidermolysis bullosa in paediatric patients
Boca Raton, Florida Wednesday, February 12, 2025, 16:00 Hrs [IST] ...
Pharmabiz6h
Clearside Biomedical presents additional data from CLS-AX ODYSSEY phase 2b trial at Angiogenesis, Exudation & Degeneration 2025 meeting
Alpharetta, Georgia Wednesday, February 12, 2025, 16:30 Hrs [IST] ...
Pharmabiz5h
WHO, St. Jude launch groundbreaking international delivery of childhood cancer medicines
WHO, St. Jude launch groundbreaking international delivery of childhood cancer medicines: Geneva Wednesday, February 12, 2025, 17:00 Hrs [IST] The World Health Organization (WHO) ...
Pharmabiz9h
EMA establishes regular procedure for scientific advice on certain high-risk medical devices
EMA establishes regular procedure for scientific advice on certain high-risk medical devices: Amsterdam, The Netherlands Wednesday, February 12, 2025, 13:00 Hrs [IST] EMA, in clos ...
Pharmabiz11h
National Organization for Rare Disorders issues new report on lifesaving newborn screening programmes
National Organization for Rare Disorders issues new report on lifesaving newborn screening programmes: Washington, D.C. Wednesday, February 12, 2025, 11:00 Hrs [IST] The National ...
Pharmabiz8h
Researchers find influenza A viruses adapt shape in response to environmental pressures
Researchers find influenza A viruses adapt shape in response to environmental pressures: Bethesda, Maryland Wednesday, February 12, 2025, 14:00 Hrs [IST] Influenza A virus particl ...
Pharmabiz10h
Glenmark Pharmaceuticals introduces clindamycin phosphate foam, 1%
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of clindamycin phosphate foam, 1%. Glenmark’s clindamycin phosphate foam, 1% is bioequivalent and therapeutically equivalent to the ...
Pharmabiz10h
Boehringer Ingelheim’s FIBRONEER-ILD phase III study of nerandomilast to treat progressive pulmonary fibrosis meets primary endpoint
Boehringer Ingelheim’s FIBRONEER-ILD phase III study of nerandomilast to treat progressive pulmonary fibrosis meets primary endpoint: Ingelheim, Germany Wednesday, February 12, ...
Pharmabiz13h
Pfizer & Astellas’ Padcev plus Keytruda shows long-term efficacy in first-line treatment of locally advanced or metastatic urothelial cancer
Pfizer & Astellas’ Padcev plus Keytruda shows long-term efficacy in first-line treatment of locally advanced or metastatic urothelial cancer: New York Wednesday, February 12, 20 ...